21 July 2023
21 July 2023
WHO’s director-general addresses further action to improve childhood immunisations globally upon the release of new data.
The latest development was based on findings from the QuANTUM-First trial of Vanflyta.
Fruquintinib is a selective and potent oral inhibitor of vascular endothelial growth factor receptor.
Astria Therapeutics hopes its candidate will become a first-choice preventative treatment for hereditary angioedema.
The centre is planned for completion in 2026, along with plans to build a $400m biologics manufacturing plant.
The National Cancer Institute funded Enspectra Health to develop deep learning algorithms to predict which skin lesions are cancerous.
During Q2 2023, international sales of the company increased 2.2%.
The EpiTAC platform of EpiBiologics aids in the tissue-specific breakdown of disease-causing membrane.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
